Literature DB >> 10411208

The scientific basis for the reputed activity of Valerian.

P J Houghton1.   

Abstract

The underground organs of members of the genus Valeriana (Valerianaceae), as well as related genera such as Nardostachys, are used in the traditional medicine of many cultures as mild sedatives and tranquillizers and to aid the induction of sleep. V. officinalis is the species most commonly used in northern Europe and still retains its official pharmacopoeial status although it is most commonly encountered as an ingredient of herbal medicines. This plant is still the subject of considerable research aimed at establishing the chemical and pharmacological basis of the activity which has been clearly shown in a number of animal and clinical studies. The constituents of the volatile oil are very variable due to population differences in genetics and to environmental factors. The major constituents include the monoterpene bornyl acetate and the sesquiterpene valerenic acid, which is characteristic of the species, in addition to other types of sesquiterpene. Some of these have been shown to have a direct action on the amygdaloid body of the brain and valerenic acid has been shown to inhibit enzyme-induced breakdown of GABA in the brain resulting in sedation. The non-volatile monoterpenes known as valepotriates were first isolated in 1966 and contribute to the overall activity by possessing sedative activity based on the CNS although the mode of action is not clearly known. The valepotriates themselves act as prodrugs which are transformed into homobaldrinal which has been shown to reduce the spontaneous motility of mice. More recent studies have shown that aqueous extracts of the roots contain appreciable amounts of GABA which could directly cause sedation but there is some controversy surrounding the bioavailability of this compound. Another recent finding is the presence of a lignan, hydroxypinoresinol, and its ability to bind to benzodiazepine receptors. Valerian is a good example of both the negative and positive aspects of herbal drugs. The considerable variation in its composition and content as well as the instability of some of its constituents pose serious problems for standardization but the range of components which contribute to its overall activity suggest that it may correct a variety of underlying causes of conditions which necessitate a general sedative or tranquilizing effect.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411208     DOI: 10.1211/0022357991772772

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  52 in total

Review 1.  Pharmacological and chemical effects of cigarette additives.

Authors:  Michael Rabinoff; Nicholas Caskey; Anthony Rissling; Candice Park
Journal:  Am J Public Health       Date:  2007-07-31       Impact factor: 9.308

Review 2.  Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.

Authors:  Will C McClatchey; Gail B Mahady; Bradley C Bennett; Laura Shiels; Valentina Savo
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

3.  Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety.

Authors:  Larry Culpepper; Mark A Wingertzahn
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-31

4.  Three new iridoids from the roots of Valeriana jatamansi.

Authors:  Jing Xu; Yuanqiang Guo; Da-qing Jin; Peng Zhao; Ping Guo; Tohru Yamakuni; Yasushi Ohizumi
Journal:  J Nat Med       Date:  2012-02-14       Impact factor: 2.343

Review 5.  Was Hawan Designed to Fight Anxiety-Scientific Evidences?

Authors:  R K Romana; A Sharma; V Gupta; R Kaur; S Kumar; P Bansal
Journal:  J Relig Health       Date:  2020-02

6.  Herbal medicines as adjuvants for cancer therapeutics.

Authors:  Chong-Zhi Wang; Tyler Calway; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2012       Impact factor: 4.667

7.  Control of development and valepotriate production by auxins in micropropagated Valeriana glechomifolia.

Authors:  C M Bello de Carvalho; N Maurmann; D I Luz; A G Fett-Neto; S B Rech
Journal:  Plant Cell Rep       Date:  2004-07-14       Impact factor: 4.570

8.  Neuroprotective properties of Valeriana officinalis extracts.

Authors:  João O Malva; Sandra Santos; Tice Macedo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

9.  Functional identification of valerena-1,10-diene synthase, a terpene synthase catalyzing a unique chemical cascade in the biosynthesis of biologically active sesquiterpenes in Valeriana officinalis.

Authors:  Yun-Soo Yeo; S Eric Nybo; Amar G Chittiboyina; Aruna D Weerasooriya; Yan-Hong Wang; Elsa Góngora-Castillo; Brieanne Vaillancourt; C Robin Buell; Dean DellaPenna; Mary Dawn Celiz; A Daniel Jones; Eve Syrkin Wurtele; Nick Ransom; Natalia Dudareva; Khaled A Shaaban; Nidhi Tibrewal; Suman Chandra; Troy Smillie; Ikhlas A Khan; Robert M Coates; David S Watt; Joe Chappell
Journal:  J Biol Chem       Date:  2012-12-14       Impact factor: 5.157

10.  Aqueous and Ethanolic Valeriana officinalis Extracts Change the Binding of Ligands to Glutamate Receptors.

Authors:  Lisa M Del Valle-Mojica; José M Cordero-Hernández; Giselle González-Medina; Igmeris Ramos-Vélez; Nairimer Berríos-Cartagena; Bianca A Torres-Hernández; José G Ortíz
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-02       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.